American Society of Clinical Oncology

SHERPA: White

People

  1. D'Angelo
    D'Angelo
  2. Dickson
    Dickson
  3. Tap
    Tap
  4. Keohan
    Keohan
  5. Gounder
    Gounder
  6. Qin
    Qin
  7. Chi
    Chi
  8. Kelly
    Kelly
  9. Antonescu
    Antonescu
  10. Singer
    Singer

Groups

  1. Department of Medicine (98)
  2. Hematologic Malignancies, Division of (98)
  3. Sarcoma Service (98)
  4. Solid Tumor Oncology Division (98)
  5. GSK Faculty (42)
  6. Tow Center for Developmental Oncology (TCDO) (35)
  7. Biostatistics Service (32)
  8. Epidemiology and Biostatistics (32)
  9. Human Oncology and Pathogenesis Program (29)
  10. Surgery (28)
Search Within
  1. "Sandra D'Angelo"
Formats
  1. Meeting Abstract (87)
  2. Journal Article (11)
Groups
  1. Department of Medicine (98)
  2. Hematologic Malignancies, Division of (98)
  3. Sarcoma Service (98)
  4. Solid Tumor Oncology Division (98)
  5. GSK Faculty (42)
  6. Tow Center for Developmental Oncology (TCDO) (35)

More Groups

People
  1. Sandra D'Angelo (98)
  2. Mark Dickson (43)
  3. William Tap (43)
  4. Mary Keohan (37)
  5. Mrinal Gounder (36)
  6. Li-Xuan Qin (27)

More People

Years
  1. 2023 (9)
  2. 2022 (8)
  3. 2021 (7)
  4. 2020 (7)
  5. 2019 (10)
  6. 2018 (7)

More Years

Publications
  1. Journal of Clinical Oncology (96)
  2. American Society of Clinical Oncology Educational Book (1)
  3. JCO Precision Oncology (1)

Results (98)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte MeĢrida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    Riedel, R. F.; Chawla, S. P.; Druta, M.; Jones, R. L.s; Schuetze, S.; Lam, J.; Zhuang, D.; Freddo, J. L.; Adams, B. J.; Theuer, C. P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma
    Meeting Abstract

    D'Angelo, S. P.; Ganjoo, K. N.; Blay, J. Y.; Valverde, C.; Araujo, D. M.; Abdul Razak, A. R.; Le Cesne, A.; Schuetze, S.; Wagner, M. J.; Attia, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma
    Meeting Abstract

    Van Tine, B. A.; Ganjoo, K. N.; Blay, J. Y.; Valverde, C.; Araujo, D. M.; Abdul Razak, A. R.; Le Cesne, A.; Schuetze, S.; Wagner, M. J.; Attia, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902)
    Meeting Abstract

    Grilley-Olson, J. E.; Allred, J. B.; Schuetze, S.; Davis, E. J.; Wagner, M. J.; Poklepovic, A. S.; Waechter, B.; Riedel, R. F.; Welliver, M. X.; Berg, S. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save